12:00 AM
Sep 21, 2015
 |  BC Week In Review  |  Company News  |  Deals

MacroGenics, J&J deal

MacroGenics received a $10 million milestone payment from Johnson & Johnson’s Janssen Biotech Inc. unit under a 2014 deal granting the...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >